You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Colorcon
Boehringer Ingelheim
AstraZeneca
Harvard Business School

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

FOLLISTIM AQ Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: FOLLISTIM AQ
Recent Clinical Trials for FOLLISTIM AQ

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Ferring PharmaceuticalsPhase 2
Center for Human ReproductionPhase 1/Phase 2
Michigan Reproductive MedicinePhase 4

See all FOLLISTIM AQ clinical trials

Company Disclosures: US Patents for FOLLISTIM AQ

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Genzyme Corporation (Cambridge, MA) 2015-06-16 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Akzo Nobel, N.V. (Arnhem, NL) 2017-01-15 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Ares Trading S.A. (Aubonne, CH) 2018-07-23 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Ares Trading S.A. (Aubonne, CH) 2018-07-23 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 002 2004-03-23   Start Trial Genzyme Corporation (Cambridge, MA) 2015-06-16 DISCN company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for FOLLISTIM AQ

These patents were identified by searching patent claims

Supplementary Protection Certificates for FOLLISTIM AQ

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
91655 Luxembourg   Start Trial 91655, EXPIRES: 20230113
10C0024 France   Start Trial PRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
122010000011 Germany   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
2010C/023 Belgium   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; AUTHORISATION NUMBER AND DATE: EU/1/09/609/001 20100126
SPC019/2010 Ireland   Start Trial SPC019/2010: 20101001, EXPIRES: 20230112
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Medtronic
Johnson and Johnson
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.